Search for Clinical Trial Results
Cholangitis - 62 Studies Found
| Status | Study |
| Completed |
Study Name: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-01-08 Interventions: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
| Withdrawn |
Study Name: The Value of CT Cholangiography in Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2007-12-26 Interventions: Procedure: CT cholangiography Cholografin 20ml will be diluted in 100 ml of normal saline and infused ov |
| Completed |
Study Name: Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-03-11 |
| Completed |
Study Name: Trial of High-dose Urso in Primary Sclerosing Cholangitis Condition: Sclerosing Cholangitis Date: 2003-04-21 Interventions: Drug: Ursodeoxycholic Acid |
| Completed |
Study Name: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2010-03-12 Interventions: Drug: ursodeoxycholic acid (UDCA) Pediatric PSC patients already receiving UDCA therapy will enter a fou |
| Completed |
Study Name: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2014-09-04 Interventions: Drug: BTT1023 IV (in the vein) Investigational Medicinal Product (IMP) |
| Completed |
Study Name: Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis Condition: Primary Biliary Cholangitis Date: 2016-06-13 Interventions:
|
| Completed |
Study Name: Minocycline in Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2008-02-27 Interventions: Drug: Minocycline Minocycline 100 mg capsules twice a day before breakfast and before dinner. |
| Not yet recruiting |
Study Name: A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-05-17 Interventions: Drug: hymecromone hymecromone treatment as described |
| Terminated |
Study Name: Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2009-08-04 Interventions: Drug: Thalidomide Titrate to 400 mg daily for 6 months |